MOBXW
MOBX
ARW
COR

Michael J. Long

Known title: DirectorCIK: 0001186373

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 6, 2026

Mobix Labs expands National Security platform with Winner Water. Mobix Labs is expanding its National Security Matters platform by integrating Winner Water, a U.S. rare earth company backed by $53 million in federal awards. This move aligns with the company's broader strategy to address critical supply chain issues. The news coincides with a volume spike and high beta activity for the warrants, reflecting increased market attention to these strategic developments.

this person other insiders at MOBXW

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 1, 2026

Mobix Labs Reports Q4 Revenue Growth Over 100%. Mobix Labs reported that its fourth-quarter revenue grew by more than 100% and gross margins were substantially higher than expected. The company also indicated that fiscal Q4 revenue is projected to exceed $1.6 million, which is above the midpoint of its previous guidance. These figures suggest strong operational performance for the period.

this person other insiders at MOBX

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 4, 2026

ARW Breaks Out on Strong Earnings Growth. Arrow Electronics was named an IBD Stock of the Day after breaking out amid triple-digit earnings growth. The stock also met specific trend template and high-growth momentum criteria, signaling strong recent performance. While one article suggests avoiding the stock, others highlight its position as a value play and a leader in the data center IT asset disposition market.

this person other insiders at ARW

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Cencora Valuation and AI Impact: Analysts Debate Growth Prospects. Recent analyses debate whether Cencora is undervalued or if its raised guidance is already priced in, as the stock trades near its 52-week high and average analyst target. Other reports suggest the company's distribution model could benefit more from AI disruption than certain telehealth competitors. The stock is also compared to major pharmaceutical companies like AbbVie and Eli Lilly as market participants assess the healthcare sector.

this person other insiders at COR

Transaction History

MOBXW▲ Buy$0
MOBXW▲ Buy$0
MOBX▲ Buy$0
MOBX▲ Buy$0
MOBX▲ Buy$0
MOBX▲ Buy$0
MOBX▲ Buy$0
MOBX▲ Buy$0
MOBX▲ Buy$0
ARW▼ Sell$87K
ARW▼ Sell$2.1M
ARW▼ Sell$603K
ARW▼ Sell$106K
ARW▼ Sell$447K
COR▲ Buy—
ARW▼ Sell$790K
ARW▼ Sell$236K
ARW▼ Sell$242K
ARW▼ Sell$359K
ARW▼ Sell$4.0M
ARW▼ Sell$301K
ARW▲ Buy$0
ARW▲ Buy$3.0M
COR▲ Buy—
ARW▼ Sell$243K
ARW▼ Sell$235K
ARW▼ Sell$238K
ARW▼ Sell$796K
ARW▲ Buy$0
ARW▼ Sell$2.5M
ARW▼ Sell$366K
ARW▲ Buy$3.0M

We use analytics to understand how market-wall is used. No personal data is sold.